BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10492215)

  • 1. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.
    Hellstrom WJ; Lewis RW
    J Urol; 1999 Oct; 162(4):1390. PubMed ID: 10492215
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.
    Subramonian K; Weston PM
    J Urol; 1999 Jul; 162(1):168-9. PubMed ID: 10379774
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of transurethal alprostadil for safety and efficacy in men with erectile dysfunction.
    Kongkanand A; Ratana-Olarn K; Wuddhikarn S; Luengwattanakit S; Tantiwong A; Ruengdilokrat S; Opanuraks J; Sripalakit S
    J Med Assoc Thai; 2002 Feb; 85(2):223-8. PubMed ID: 12081123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of transurethral application of alprostadil for erectile dysfunction in Indonesians.
    Pangkahila WI
    Asian J Androl; 2000 Sep; 2(3):233-6. PubMed ID: 11225984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of intraurethral alprostadil in patients not responding to sildenafil citrate.
    Jaffe JS; Antell MR; Greenstein M; Ginsberg PC; Mydlo JH; Harkaway RC
    Urology; 2004 May; 63(5):951-4. PubMed ID: 15134987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraurethral alprostadil for impotence.
    Med Lett Drugs Ther; 1997 Mar; 39(997):32. PubMed ID: 9121395
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical conversations: intraurethral alprostadil (MUSE). Interview by Patricia Bates.
    Lewis J; Helfrick B; Marzucco J
    Urol Nurs; 1997 Dec; 17(4):159-61. PubMed ID: 9451246
    [No Abstract]   [Full Text] [Related]  

  • 8. [Place of intra-urethral prostaglandin E1 for the treatment of erectile dysfunction].
    Amar E
    Contracept Fertil Sex; 1999; 27(7-8):548-52. PubMed ID: 10495573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transurethral alprostadil (MUSE) in erectile dysfunction].
    Comeri G; Gianneo E; Nespoli R
    Arch Ital Urol Androl; 1999 Sep; 71(4):249-51. PubMed ID: 10592541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of a topical alprostadil cream, Alprox-TD, for the treatment of erectile dysfunction: two phase 2 studies in mild-to-moderate and severe ED.
    Padma-Nathan H; Steidle C; Salem S; Tayse N; Yeager J; Harning R
    Int J Impot Res; 2003 Feb; 15(1):10-7. PubMed ID: 12605235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction.
    Lewis RW
    Int J Impot Res; 1998 Mar; 10(1):61-2. PubMed ID: 9542692
    [No Abstract]   [Full Text] [Related]  

  • 12. Penile rigidity in erectile dysfunction treated with alprostadil.
    Greco E; Polonio-Balbi P
    Lancet; 1997 Dec; 350(9092):1682. PubMed ID: 9400524
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors in predicting initial in-office therapeutic dosages of alprostadil for the treatment of organic impotence.
    Intili H
    Urol Nurs; 1998 Jun; 18(2):111-3. PubMed ID: 9866639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
    Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
    Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil.
    Hellstrom WJ; Bennett AH; Gesundheit N; Kaiser FE; Lue TF; Padma-Nathan H; Peterson CA; Tam PY; Todd LK; Varady JC; Place VA
    Urology; 1996 Dec; 48(6):851-6. PubMed ID: 8973666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice.
    Rajpurkar A; Dhabuwala CB
    J Urol; 2003 Jul; 170(1):159-63. PubMed ID: 12796670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalassaemic men affected by erectile dysfunction treated with transurethral alprostadil: case report.
    Lombardo T; Giammusso B; Frontini V; D'Arpa S; Pafumi C; Caruso S
    Hum Reprod; 2000 Nov; 15(11):2375-8. PubMed ID: 11056136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group B streptococcal septicemia following intracavernous injection therapy for erectile dysfunction in diabetes.
    Nalesnik JG; Jones L; Kraus SR
    J Urol; 2004 Jul; 172(1):151-2. PubMed ID: 15201758
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: The lowest effective dose of prostaglandin E1 as treatment for erectile dysfunction.
    Kim YC
    J Urol; 1995 Nov; 154(5):1870-1. PubMed ID: 7563372
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prostaglandin in the treatment of impotence].
    Tammela T
    Duodecim; 1998; 114(4):371-5. PubMed ID: 11466950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.